-
Developments & Potential of Nanotechnology for the Detection and Treatment of Pancreatic Cancer
04 Feb 2026 23:47 GMT
… Onyvide with or without 5-FU/LV or 5-FU & LV. Results … Amrutkar M, Gladhaug IP. Pancreatic cancer chemoresistance to gemcitabine. Cancers. 2017;9(11):157. doi: … 3 study of liposomal irinotecan + 5-fluorouracil/leucovorin + oxaliplatin (NALIRIFOX) versus …
-
Single-Cell Spheroids Reveal Colorectal Cancer’s Heterogeneity
24 Jan 2026 19:08 GMT
… response to treatments like 5-fluorouracil (5-FU).
Colorectal cancer, a leading cause of … sensitivity to 5-FU, a widely used chemotherapeutic agent in colorectal cancer treatment. … can influence the efficacy of chemotherapy, suggesting that future therapeutic …
-
Targeting Thymidylate Synthase Boosts Cervical Cancer Immunity
19 Jan 2026 13:40 GMT
… long-standing target for chemotherapeutic agents such as 5-fluorouracil (5-FU). While the enzyme … in cancer immunitycervical cancer immunotherapy advancementscervical cancer research breakthroughscervical cancer treatment innovationsdual-function cancer …
-
Black Grape Anthocyanins Boost 5-FU Cancer Therapy
29 Dec 2025 14:16 GMT
… sensitize cancer cells to a commonly used chemotherapy drug, 5-fluorouracil (5-FU). … and lethal cancers worldwide. Conventional chemotherapy, including 5-FU, often encounters … -03177-3
Tags: 5-FU chemosensitivity enhancementantioxidant properties of black …
-
<![CDATA[From Biologics to Bio-Machines: Top Takeaways From Maui Derm 2026]]>
04 Feb 2026 04:03 GMT
… ) and keratinocyte cancers. The role of topical therapies such as 5-fluorouracil (5-FU) and … maximize efficacy and minimize toxicity.
Chemopreventive strategies like niacinamide continue to …
-
Combinatorial Anti-Mitotic Activity of Loratadine/5-Fluorouracil Loaded Zein Tannic Acid Nanoparticles in Breast Cancer Therapy: In silico, in vitro and Cell Studies
15 Jan 2026 07:56 GMT
… colorectal cancer. 5-FU is considered as one of the most widely used chemotherapy … selected drugs, loratadine (LOR) and 5-Fluorouracil (5-FU), with two naturally derived polymers … effects of various treatments (free 5-Fluorouracil (5-FU), ZN/TAN NPs, …
-
Capecitabine Dosage as an Independent Prognostic Factor for the Development of Hand-Foot Syndrome: A Competing Risk Analysis
03 Feb 2026 23:50 GMT
… prodrug widely used in cancer chemotherapy, is converted to 5-fluorouracil (5-FU) in the liver … syndrome in cancer patients receiving infusional 5-fluorouracil or oral capecitabine-containing chemotherapy regimens …
-
<![CDATA[Radiotherapy Dose Escalation Did Not Improve Efficacy/QOL in Anal Cancer]]>
12 Jan 2026 19:46 GMT
… Society of Clinical Oncology Gastrointestinal Cancer Symposium.
A complete response … radiotherapy, and 18% were given 5-fluorouracil (5-FU) plus radiotherapy.
Disease characteristics … randomised trial: personalizing anal cancer radiotherapy dose. J Clin …
-
<![CDATA[Zanidatamab Plus Chemo ± Tislelizumab May Replace First-Line Standard of Care in HER2+ Gastroesophageal Adenocarcinoma]]>
09 Jan 2026 04:37 GMT
… plus oxaliplatin (CAPOX) or 5-fluorouracil (5-FU) plus cisplatin
Arm B: … zanidatamab plus chemotherapy in patients with HER2-positive breast cancer7
Disclosures: … combination with chemotherapy in participants with HER2-positive breast cancer (EmpowHER …
-
Mira Precision Health, Based in Mason, Ohio, Announces U.S. Launch of ToxNav® Advantage™ at the 2026 ASCO® GI Cancers Symposium
05 Jan 2026 14:47 GMT
… -threatening toxicities from fluoropyrimidine-based chemotherapies, including 5-fluorouracil (5-FU) and capecitabine (XELODA®).
This … incorporating genetic variants associated with cancer therapy–related cardiac dysfunction (CTRCD …
About
© 1995-2026